These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

264 related items for PubMed ID: 21839245

  • 41. Randomized controlled study comparing reduced calcineurin inhibitors exposure versus standard cyclosporine-based immunosuppression.
    Hernández D, Miquel R, Porrini E, Fernández A, González-Posada JM, Hortal L, Checa MD, Rodríguez A, García JJ, Rufino M, Torres A.
    Transplantation; 2007 Sep 27; 84(6):706-14. PubMed ID: 17893603
    [Abstract] [Full Text] [Related]

  • 42. The impact of tacrolimus as rescue therapy in children using a double immunosuppressive regimen after heart transplantation.
    Branco KC, Azeka E, Trindade E, Galas FR, Hajjar LA, Benvenuti L, Riso A, Tanamati C, Penha J, Auler JO, Jatene M.
    Transplant Proc; 2012 Oct 27; 44(8):2483-5. PubMed ID: 23026625
    [Abstract] [Full Text] [Related]

  • 43. Comparison of cyclosporine microemulsion and tacrolimus in 39 recipients of living donor liver transplantation.
    Tanaka K, Lake J, Villamil F, Levy G, Marotta P, Mies S, de Hemptinne B, Moench C.
    Liver Transpl; 2005 Nov 27; 11(11):1395-402. PubMed ID: 16237691
    [Abstract] [Full Text] [Related]

  • 44. Outcome of recurrent hepatitis C virus after liver transplantation in a randomized trial of tacrolimus monotherapy versus triple therapy.
    Manousou P, Samonakis D, Cholongitas E, Patch D, O'Beirne J, Dhillon AP, Rolles K, McCormick A, Hayes P, Burroughs AK.
    Liver Transpl; 2009 Dec 27; 15(12):1783-91. PubMed ID: 19938143
    [Abstract] [Full Text] [Related]

  • 45. Increased incidence of early de novo cancer in liver graft recipients treated with cyclosporine: an association with C2 monitoring and recipient age.
    Tjon AS, Sint Nicolaas J, Kwekkeboom J, de Man RA, Kazemier G, Tilanus HW, Hansen BE, van der Laan LJ, Tha-In T, Metselaar HJ.
    Liver Transpl; 2010 Jul 27; 16(7):837-46. PubMed ID: 20583092
    [Abstract] [Full Text] [Related]

  • 46. Comparison of tacrolimus and cyclosporin in renal transplantation by the protocol biopsies.
    Töz H, Sen S, Seziş M, Duman S, Ozkahya M, Ozbek S, Hoşcoşkun C, Atabay G, Ok E.
    Transplant Proc; 2004 Jul 27; 36(1):134-6. PubMed ID: 15013324
    [Abstract] [Full Text] [Related]

  • 47. 12-month follow-up analysis of a multicenter, randomized, prospective trial in de novo liver transplant recipients (LIS2T) comparing cyclosporine microemulsion (C2 monitoring) and tacrolimus.
    Levy G, Grazi GL, Sanjuan F, Wu Y, Mühlbacher F, Samuel D, Friman S, Jones R, Cantisani G, Villamil F, Cillo U, Clavien PA, Klintmalm G, Otto G, Pollard S, McCormick PA.
    Liver Transpl; 2006 Oct 27; 12(10):1464-72. PubMed ID: 17004259
    [Abstract] [Full Text] [Related]

  • 48. Survival and allograft rejection rates after combined heart and kidney transplantation in comparison with heart transplantation alone.
    Czer LS, Ruzza A, Vespignani R, Jordan S, De Robertis MA, Mirocha J, Gallagher SP, Patel K, Schwarz ER, Kass RM, Trento A.
    Transplant Proc; 2011 Dec 27; 43(10):3869-76. PubMed ID: 22172862
    [Abstract] [Full Text] [Related]

  • 49.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 50.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 51.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 52.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 53.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 54.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 55.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 56. Effect of calcineurin inhibitors in the outcome of liver transplantation in hepatitis C virus-positive recipients.
    Berenguer M, Aguilera V, San Juan F, Benlloch S, Rubin A, López-Andujar R, Moya A, Pareja E, Montalva E, Yago M, de Juan M, Mir J, Prieto M.
    Transplantation; 2010 Dec 15; 90(11):1204-9. PubMed ID: 21068701
    [Abstract] [Full Text] [Related]

  • 57. Superior rejection profile during the first 24 months after heart transplantation under tacrolimus as baseline immunosuppressive regimen.
    Helmschrott M, Beckendorf J, Akyol C, Ruhparwar A, Schmack B, Erbel C, Gleissner CA, Akhavanpoor M, Ehlermann P, Bruckner T, Katus HA, Doesch AO.
    Drug Des Devel Ther; 2014 Dec 15; 8():1307-14. PubMed ID: 25246772
    [Abstract] [Full Text] [Related]

  • 58.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 59. Preventing cardiac allograft vasculopathy: long-term beneficial effects of mycophenolate mofetil.
    Kaczmarek I, Ertl B, Schmauss D, Sadoni S, Knez A, Daebritz S, Meiser B, Reichart B.
    J Heart Lung Transplant; 2006 May 15; 25(5):550-6. PubMed ID: 16678034
    [Abstract] [Full Text] [Related]

  • 60.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 14.